Fortress Biotech, Inc.

Track

Insider profile

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Fortress Biotech, Inc.'s trades of Checkpoint Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
481.50
Quantity 752 +13.9%
Value US$1,207,895
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-03 2025-05-29
S Sale
33,730 +3.2%
31.11
US$3,962,542 		33,730 +3.2% 31.11 US$3,962,542
2023-09-12 2023-09-08
B Purchase
752 +13.9%
481.50
US$1,207,895 		752 +13.9% 481.50 US$1,207,895